OBJECTIVES: To estimate the burden of Lassa fever in northern and central Edo, a state in south Nigeria where Lassa fever has been reported. METHODS: Blood samples were obtained from 60 patients hospitalised at the Irrua Specialist Teaching Hospital (ISTH), Irrua, with a clinical suspicion of Lassa fever and from 451 febrile outpatients seen at the ISTH and hospitals in Ekpoma, Iruekpen, Uromi, Auchi and Igarra. All samples were tested retrospectively by Lassa virus-specific RT-PCR. Outpatients were additionally screened for Lassa virus-specific antibodies by indirect immunofluorescent antibody assay. RESULTS: Lassa virus was detected in 25 of 60 (42%) patients with a clinical suspicion of Lassa fever. The disease affected persons of all age groups and with various occupations, including healthcare workers. The clinical picture was dominated by gastrointestinal symptoms. The case fatality rate was 29%. Lassa virus was detected in 2 of 451 (0.44%) febrile outpatients, and 8 (1.8%) were positive for Lassa virus-specific IgG. CONCLUSIONS: Lassa fever contributes to hospital mortality in Edo State. The low prevalence of the disease among outpatients and the low seroprevalence may indicate that the population-level incidence is not high. Surveillance for Lassa fever should focus on the hospitalised patient.
OBJECTIVES: To estimate the burden of Lassa fever in northern and central Edo, a state in south Nigeria where Lassa fever has been reported. METHODS: Blood samples were obtained from 60 patients hospitalised at the Irrua Specialist Teaching Hospital (ISTH), Irrua, with a clinical suspicion of Lassa fever and from 451 febrile outpatients seen at the ISTH and hospitals in Ekpoma, Iruekpen, Uromi, Auchi and Igarra. All samples were tested retrospectively by Lassa virus-specific RT-PCR. Outpatients were additionally screened for Lassa virus-specific antibodies by indirect immunofluorescent antibody assay. RESULTS:Lassa virus was detected in 25 of 60 (42%) patients with a clinical suspicion of Lassa fever. The disease affected persons of all age groups and with various occupations, including healthcare workers. The clinical picture was dominated by gastrointestinal symptoms. The case fatality rate was 29%. Lassa virus was detected in 2 of 451 (0.44%) febrile outpatients, and 8 (1.8%) were positive for Lassa virus-specific IgG. CONCLUSIONS:Lassa fever contributes to hospital mortality in Edo State. The low prevalence of the disease among outpatients and the low seroprevalence may indicate that the population-level incidence is not high. Surveillance for Lassa fever should focus on the hospitalised patient.
Authors: Henrieke A B Prins; Peter Mugo; Elizabeth Wahome; Grace Mwashigadi; Alexander Thiong'o; Adrian Smith; Eduard J Sanders; Susan M Graham Journal: Int Health Date: 2014-05-19 Impact factor: 2.473
Authors: Nathan Y Shehu; Simji S Gomerep; Samson E Isa; Kelly O Iraoyah; Johnson Mafuka; Nandom Bitrus; Matthias C Dachom; John E Ogwuche; Asukwo E Onukak; Kenneth I Onyedibe; Ephraim Ogbaini-Emovon; Daniel Z Egah; Elizabeth J Mateer; Slobodan Paessler Journal: Front Public Health Date: 2018-08-29
Authors: Louise Sigfrid; Catrin Moore; Alex P Salam; Nicola Maayan; Candyce Hamel; Chantelle Garritty; Vittoria Lutje; Brian Buckley; Karla Soares-Weiser; Rachel Marshall; Mike Clarke; Peter Horby Journal: BMC Med Date: 2019-06-11 Impact factor: 8.775
Authors: Laura Merson; Josephine Bourner; Sulaiman Jalloh; Astrid Erber; Alex Paddy Salam; Antoine Flahault; Piero L Olliaro Journal: PLoS Negl Trop Dis Date: 2021-09-21
Authors: Peter O Okokhere; Idowu A Bankole; Christopher O Iruolagbe; Benard E Muoebonam; Martha O Okonofua; Simeon O Dawodu; George O Akpede Journal: Case Rep Neurol Med Date: 2016-11-13
Authors: Odigie C Akhuemokhan; Rosemary O Ewah-Odiase; Nosa Akpede; Jacqueline Ehimuan; Donatus I Adomeh; Ikpomwonsa Odia; Sylvia C Olomu; Meike Pahlmann; Beate Becker-Ziaja; Christian T Happi; Danny A Asogun; Sylvanus A Okogbenin; Peter O Okokhere; Osagie S Dawodu; Irekpono U Omoike; Pardis C Sabeti; Stephan Günther; George O Akpede Journal: PLoS Negl Trop Dis Date: 2017-07-03